The polycomb repressive complex 2 is a potential target of SUMO modifications.
about
Polycomb Group (PcG) Proteins and Human Cancers: Multifaceted Functions and Therapeutic ImplicationsPRC2 during vertebrate organogenesis: a complex in transitionEZH2 in Bladder Cancer, a Promising Therapeutic TargetMale germ cell apoptosis and epigenetic histone modification induced by Tripterygium wilfordii Hook FSUMO-specific protease 2 is essential for suppression of polycomb group protein-mediated gene silencing during embryonic development.A manually curated network of the PML nuclear body interactome reveals an important role for PML-NBs in SUMOylation dynamics.Regulation and Role of EZH2 in CancerConditional ablation of Ezh2 in murine hearts reveals its essential roles in endocardial cushion formation, cardiomyocyte proliferation and survival.Small ubiquitin-like modifier (SUMO) conjugation impedes transcriptional silencing by the polycomb group repressor Sex Comb on MidlegEstrogen receptor alpha and nuclear factor Y coordinately regulate the transcription of the SUMO-conjugating UBC9 gene in MCF-7 breast cancer cells.An RNAi-based dimorphic genetic screen identified the double bromodomain protein BET-1 as a sumo-dependent attenuator of RAS-mediated signallingSex comb on midleg (Scm) is a functional link between PcG-repressive complexes in DrosophilaSUMO: a multifaceted modifier of chromatin structure and function.Multifaceted role of EZH2 in breast and prostate tumorigenesis: epigenetics and beyond.Sumoylation and regulation of cardiac gene expression.Defective sumoylation pathway directs congenital heart diseaseTalking to chromatin: post-translational modulation of polycomb group function.Regulation and role of post-translational modifications of enhancer of zeste homologue 2 in cancer developmentComplexity of polycomb group function: diverse mechanisms of target specificity.Emerging roles of the SUMO pathway in development.Modulation of gene expression in ovarian cancer by active and repressive histone marks.Roles of enhancer of zeste homolog 2: from skeletal muscle differentiation to rhabdomyosarcoma carcinogenesis.Inhibition of protein SUMOylation by davidiin, an ellagitannin from Davidia involucrata.Polycomb repressive complex 2 regulates normal development of the mouse heartAlternative Splicing of EZH2 pre-mRNA by SF3B3 Contributes to the Tumorigenic Potential of Renal Cancer.PIAS2-2 SUMOylates SUZ12 with SUMO1Introduction to Sumoylation.Role of novel histone modifications in cancer.The HDAC inhibitor SAHA regulates CBX2 stability via a SUMO-triggered ubiquitin-mediated pathway in leukemia.
P2860
Q26801380-C8F63AEA-8269-4358-9D54-B22797215624Q26821792-7C655643-26D7-406A-97E4-26D446CFE340Q28082054-D9ADA1BF-C465-4A24-A5BF-926325D3F2EDQ28478589-1949DE21-6A2D-409A-9321-EA7EEDF39C6DQ28589417-072E3DE2-1CBD-410E-B728-B71D303E0725Q33596988-0CA035D2-4294-4209-A873-D5885D6FEB2EQ34043370-D1F590D1-58F4-4949-9F5E-5F6589D0B83DQ34152677-D145ECB2-A1CC-4837-8F2C-35C6AD991DACQ34719656-EC82AB69-10B6-4564-9A62-8F3515C9E26AQ35005904-6C5E0FA0-5139-405D-AB60-43578807CCCAQ35071050-5CAEAFED-0AD7-483B-BBCC-8B8F3C16AD27Q35750780-50F61E7E-637D-473F-B12A-42DA13AD5FD9Q36564384-94380145-29A9-4553-9C4F-FD251FBDE5FEQ37089496-C9D8A33F-6476-409C-8272-9EF285C9D4FAQ37097348-6B29EA1E-B59A-40B4-942D-49F1A9AE6B39Q37273083-8730850F-78BD-437A-A2FA-9076A99F24B7Q37350145-4039864B-A8B6-43B1-883E-1A0CDB1CA665Q37545071-CCD4B217-8160-4DEE-ABF4-DEBE7E79DEADQ37783587-0587464B-2B26-4B83-AF6F-E64D806812BBQ37926562-9A86D9F4-AE93-4788-857B-DCA57F5D9752Q37962015-DB781E0D-901A-4485-B454-24FF8D70B15EQ38185265-698535E4-EC7E-481F-8E56-94F366F80E25Q39034419-4F1B8380-9768-45B1-9193-739147934681Q41259507-884F4C00-6A6A-4FD0-9951-F3B0C673ACB9Q46629789-59FEC01C-02D8-4872-A589-9AC5694C204DQ50296464-02FB1413-8414-4596-B0D3-9545D2C009D6Q51137622-9B1A7E9E-0257-4B01-80C4-1B1E41AB2D6AQ52655031-450FC4A9-DF3D-4859-B642-3202AB1ECF67Q52691495-D95025AA-685B-4184-9353-AA291A0FB97A
P2860
The polycomb repressive complex 2 is a potential target of SUMO modifications.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
The polycomb repressive complex 2 is a potential target of SUMO modifications.
@ast
The polycomb repressive complex 2 is a potential target of SUMO modifications.
@en
type
label
The polycomb repressive complex 2 is a potential target of SUMO modifications.
@ast
The polycomb repressive complex 2 is a potential target of SUMO modifications.
@en
prefLabel
The polycomb repressive complex 2 is a potential target of SUMO modifications.
@ast
The polycomb repressive complex 2 is a potential target of SUMO modifications.
@en
P2860
P50
P1433
P1476
The polycomb repressive complex 2 is a potential target of SUMO modifications.
@en
P2093
Roberto Boggio
Susanna Chiocca
P2860
P356
10.1371/JOURNAL.PONE.0002704
P407
P577
2008-07-16T00:00:00Z